外泌体在医学领域的应用
Application of Exosomes in Medical Field
DOI: 10.12677/ACM.2023.132185, PDF,   
作者: 赵 鹏:青海大学,青海 西宁;马文宇:青海大学附属医院,青海 西宁
关键词: 外泌体医学应用Exosomes Medical Application
摘要: 外泌体是一种存在于细胞外囊泡中的物质,且其含有多种成分,如蛋白质、脂质和核酸等,是一种双磷脂膜囊泡。外泌体几乎由人体所有的细胞分泌,在各种体液中都能检测到,在细胞间的连接中占有举足轻重的地位。外泌体的作用表现为细胞间的连接,免疫调节,信号传导细胞的再生和分化,形成血管,凋亡,呈递抗原等。并且外泌体所含成分具有明显的特异性,利用此特性,如癌症及病毒感染、多囊卵巢症候群等,其可视为疾病的生物标记,作为诊断之用。外泌体也曾尝试作为载体,将药物输送出去,如一些抗肿瘤药的应用。外泌体在疾病中行使的功能使它在临床上的应用具有很大的优越性。本文主要从外泌体的发现、及其在相关疾病(皮肤创面修复,阿尔茨海默病,肿瘤治疗)的研究进展这2个方面加以阐述。
Abstract: Exosomes are substances existing in extracellular vesicles, and they contain a variety of compo-nents, such as protein, lipid and nucleic acid. They are double phospholipid membrane vesicles. The exosomes are secreted by almost all cells of the human body, can be detected in various body fluids, and play an important role in the connection between cells. The functions of exosomes include cell to cell connection, immune regulation, regeneration and differentiation of signal transduction cells, formation of blood vessels, apoptosis, antigen presentation, etc. In addition, the components con-tained in the exosomes have obvious specificity. With this characteristic, such as cancer, virus infec-tion, polycystic ovary syndrome, etc., they can be regarded as biomarkers of diseases for diagnosis. The exosomes have also tried to be used as carriers to deliver drugs, such as the application of some anti-tumor drugs. The function of exocrine body in disease makes it have great advantages in clini-cal application. This article mainly discusses the discovery of exocrine body and its research pro-gress in related diseases (skin wound repair, Alzheimer’s disease, tumor treatment).
文章引用:赵鹏, 马文宇. 外泌体在医学领域的应用[J]. 临床医学进展, 2023, 13(2): 1341-1345. https://doi.org/10.12677/ACM.2023.132185

参考文献

[1] Kourembanas, S. (2015) Exosomes Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy. Annual Review of Physiology, 77, 13-27. [Google Scholar] [CrossRef] [PubMed]
[2] Pan, B.T. and Johnstone, R.M. (1983) Fate of the Transferrin Receptor during Maturation of Sheep Reticulocytes in Vitro: Selective Externalization of the Receptor. Cell, 33, 967-978. [Google Scholar] [CrossRef] [PubMed]
[3] Johnstone, R.M., Adam, M., Hammond, J.R., et al. (1987) Vesicle Formation during Reticulocyte Maturation. Association of Plas-ma Membrane Activities with Released Vesicles (Exosomes). Journal of Biological Chemistry, 262, 9412-9420. [Google Scholar] [CrossRef
[4] Raposo, G. and Stoorvogel, W. (2013) Extracellular Vesicles: Exosomes, Microvesicles, and Friends. Journal of Cell Biology, 200, 373-383. [Google Scholar] [CrossRef] [PubMed]
[5] Tkach, M. and Thery, C. (2016) Communication by Extracellular Vesi-cles: Where We Are and Where We Need to Go. Cell, 164, 1226-1232. [Google Scholar] [CrossRef] [PubMed]
[6] Lipsky, P.E. (2001) Systemic Lupus Erythematosus: An Autoim-mune Disease of B Cell Hyperactivity. Nature Immunology, 2, 764-766. [Google Scholar] [CrossRef] [PubMed]
[7] Nosbaum, A., Prevel, N., Truong, H.-A., et al. (2016) Regulatory T Cells Facilitate Cutaneous Wound Healing. The Journal of Immunology, 196, 2010-2014. [Google Scholar] [CrossRef] [PubMed]
[8] Monguió-Tortajada, M., Roura, S., Gálvez-Montón, C., et al. (2017) Nanosized UCMSC-Derived Extracellular Vesicles but Not Conditioned Medium Exclusively Inhibit the Inflam-matory Response of Stimulated T Cells: Implications for Nanomedicine. Theranostics, 7, 270-284. [Google Scholar] [CrossRef] [PubMed]
[9] Hatanaka, E., Monteagudo, P.T., Marrocos, M.S.M., et al. (2006) Neu-trophils and Monocytes as Potentially Important Sources of Proinflammatory Cytokines in Diabetes. Clinical & Experi-mental Immunology, 146, 443-447. [Google Scholar] [CrossRef] [PubMed]
[10] Yang, J., Liu, X.X., Fan, H., et al. (2015) Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Co-lon Inflammation, Oxidative Stress and Apoptosis. PLOS ONE, 10, e0140551. [Google Scholar] [CrossRef] [PubMed]
[11] Li, X., Liu, L., Yang, J., et al. (2016) Exosome Derived from Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-Induced Excessive Inflammation. EBioMedicine, 8, 72-82. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, J., Guan, J., Niu, X., et al. (2015) Exosomes Released from Human Induced Pluripotent Stem Cells-Derived MSCs Facilitate Cutaneous Wound Healing by Promoting Colla-gen Synthesis and Angiogenesis. Journal of Translational Medicine, 13, 49. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, B., Wu, X., Zhang, X., et al. (2015) Human Umbilical Cord Mesenchymal Stem Cell Exosomes Enhance Angiogenesis through the Wnt4/β-Catenin Pathway. Stem Cells Translational Medicine, 4, 513-522. [Google Scholar] [CrossRef] [PubMed]
[14] Guo, S.C., Tao, S.C., Yin, W.J., et al. (2017) Exosomes Derived from Platelet-Rich Plasma Promote the Re-Epithelization of Chronic Cutaneous Wounds via Activation of YAP in a Dia-betic Rat Model. Theranostics, 7, 81-96. [Google Scholar] [CrossRef] [PubMed]
[15] Jia, L., Qiu, Q., Zhang, H., et al. (2019) Concordance between the Assessment of Abeta42, T-Tay, and P-T181-Tauinperipheral Blood Neuronal-Derived Exosomes and Cerebrospinal Fluid. Alzheimer’s & Dementia, 15, 1071. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Y., Meng, S., Di, W., et al. (2022) Amyloid-beta Protein and MicroRNA-384 in NCAM-Labeled Exosomes from Peripheral Blood Are Potential Diagnostic Markers for Alzheimer’s Disease. CNS Neuroscience & Therapeutics, 28, 1093. [Google Scholar] [CrossRef] [PubMed]
[17] Goetzl, E.J., Abner, E.L., Jicha, G.A., et al. (2018) Declining Levels of Functional Lyspecialized Synaptic Proteins in Plasma Neuronal Exo-somes with Progression of Alzheimer’s Disease. The FASEB Journal, 32, 888. [Google Scholar] [CrossRef
[18] Soaresmartins, T., Trindade, D., Vaz, M., et al. (2021) Diagnostic and Therapeutic Potential of Exosomes in Alzheimer’s Disease. Journal of Neurochemistry, 156, 162. [Google Scholar] [CrossRef] [PubMed]
[19] Alvares-erviti, L., Seow, Y., Yin, H., et al. (2011) Delivery of siRNA to the Mouse Brain by Systemic Injection of Targeted Exosomes. Nature Biotechnology, 29, 341. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, W., Huang, Y., Han, J., et al. (2016) Immunomodulatory Effects of Mesenchymal Stromal Cells-Derived Exosome. Immunologic Research, 64, 831. [Google Scholar] [CrossRef] [PubMed]
[21] Kzhyshkowska, J., Bizzarri, M., Apte, R., et al. (2017) Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy. Current Pharmaceuti-cal Design, 23, 4703-4704. [Google Scholar] [CrossRef] [PubMed]
[22] Escudier, B., Dorval, T., Chaput, N., et al. (2005) Vac-cination of Metastatic Melanoma Patients with Autologous Dendritic Cell (DC) Derived-Exosomes: Results of the First Phase I Clinical Trial. Journal of Translational Medicine, 3, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[23] Sun, W., Luo, J.D., Jiang, H. and Duan, D.D. (2018) Tumor Exo-somes: A Double-Edged Sword in Cancer Therapy. Acta Pharmacologica Sinica, 39, 534-541. [Google Scholar] [CrossRef] [PubMed]